Cargando…
Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375202/ https://www.ncbi.nlm.nih.gov/pubmed/32700057 http://dx.doi.org/10.1007/s00259-020-04964-y |
| _version_ | 1783561834778853376 |
|---|---|
| author | Le Roux, Pierre-Yves Le Gal, Grégoire Salaun, Pierre-Yves |
| author_facet | Le Roux, Pierre-Yves Le Gal, Grégoire Salaun, Pierre-Yves |
| author_sort | Le Roux, Pierre-Yves |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7375202 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73752022020-07-23 Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study? Le Roux, Pierre-Yves Le Gal, Grégoire Salaun, Pierre-Yves Eur J Nucl Med Mol Imaging Letter to the Editor Springer Berlin Heidelberg 2020-07-22 2020 /pmc/articles/PMC7375202/ /pubmed/32700057 http://dx.doi.org/10.1007/s00259-020-04964-y Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Le Roux, Pierre-Yves Le Gal, Grégoire Salaun, Pierre-Yves Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study? |
| title | Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study? |
| title_full | Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study? |
| title_fullStr | Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study? |
| title_full_unstemmed | Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study? |
| title_short | Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study? |
| title_sort | lung scintigraphy for pulmonary embolism diagnosis during the covid-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375202/ https://www.ncbi.nlm.nih.gov/pubmed/32700057 http://dx.doi.org/10.1007/s00259-020-04964-y |
| work_keys_str_mv | AT lerouxpierreyves lungscintigraphyforpulmonaryembolismdiagnosisduringthecovid19pandemicdoesthebenefitriskratioreallyjustifyomittingtheventilationstudy AT legalgregoire lungscintigraphyforpulmonaryembolismdiagnosisduringthecovid19pandemicdoesthebenefitriskratioreallyjustifyomittingtheventilationstudy AT salaunpierreyves lungscintigraphyforpulmonaryembolismdiagnosisduringthecovid19pandemicdoesthebenefitriskratioreallyjustifyomittingtheventilationstudy |